|
1
|
T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
|
JACC Cardiovasc Imaging
|
2013
|
4.21
|
|
2
|
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
|
JACC Cardiovasc Imaging
|
2013
|
3.53
|
|
3
|
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
|
Circ Cardiovasc Imaging
|
2013
|
1.99
|
|
4
|
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
|
N Engl J Med
|
2015
|
1.84
|
|
5
|
Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.
|
Clin Chem
|
2007
|
1.66
|
|
6
|
Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
|
Circ Cardiovasc Imaging
|
2012
|
1.25
|
|
7
|
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
|
J Cardiovasc Magn Reson
|
2014
|
0.97
|
|
8
|
Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.
|
Clin Chem
|
2007
|
0.91
|
|
9
|
Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure.
|
Clin Chem
|
2007
|
0.89
|
|
10
|
Clinical relevance of non-cardiac determinants of natriuretic peptide levels.
|
Clin Chem Lab Med
|
2008
|
0.84
|
|
11
|
The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis.
|
Clin Chim Acta
|
2009
|
0.83
|
|
12
|
Selective right ventricular impairment following coronary artery bypass graft surgery.
|
Eur J Cardiothorac Surg
|
2009
|
0.81
|
|
13
|
CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers.
|
JACC Cardiovasc Imaging
|
2013
|
0.80
|
|
14
|
Prognostic value of plasma renin activity in heart failure.
|
Am J Cardiol
|
2011
|
0.80
|
|
15
|
The empowerment of translational research: lessons from laminopathies.
|
Orphanet J Rare Dis
|
2012
|
0.80
|
|
16
|
Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
|
J Card Fail
|
2008
|
0.78
|
|
17
|
T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.
|
Expert Rev Cardiovasc Ther
|
2014
|
0.75
|
|
18
|
Reply: Myocardial extracellular volume measurement by cardiac magnetic resonance.
|
JACC Cardiovasc Imaging
|
2014
|
0.75
|
|
19
|
Cardiovascular magnetic resonance in the evaluation of heart failure: a luxury or a need?
|
J Cardiovasc Med (Hagerstown)
|
2012
|
0.75
|
|
20
|
Heart muscle disease and cardiovascular magnetic resonance imaging.
|
Br J Hosp Med (Lond)
|
2014
|
0.75
|
|
21
|
CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy.
|
JACC Cardiovasc Imaging
|
2017
|
0.75
|
|
22
|
[Cardiomyopathy and hypereosinophilia: a post-partum case].
|
Recenti Prog Med
|
2009
|
0.75
|
|
23
|
Natriuretic peptide testing in primary care patients.
|
Clin Chem Lab Med
|
2008
|
0.75
|
|
24
|
Should Histologic Determination of Amyloid Load Determine Management Decisions in Light-Chain Amyloidosis?
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
25
|
Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure.
|
Adv Clin Chem
|
2009
|
0.75
|
|
26
|
[Differential diagnosis of dyspnea: the incremental value of lung ultrasound].
|
Recenti Prog Med
|
2010
|
0.75
|